Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pachymic acid is a triterpenoid that has been found in P. cocos and has diverse biological activities.1,2,3,4 It inhibits hexokinase 2 (HK2; IC50 = 5.01 µM), as well as reduces glucose uptake and lactate production in SK-BR-3 breast cancer cells.1 Pachymic acid inhibits IL-1β-induced cytosolic phospholipase A2 (cPLA2) activation and prostaglandin E2 (PGE2; Item No. 14010) production in, as well as inhibits the proliferation of, A549 lung cancer cells.2 It decreases tumor growth in an NCI H23 lung cancer mouse xenograft model when administered at doses of 30 and 60 mg/kg.3 Pachymic acid (10 and 20 mg/kg) prevents increases in serum urea and creatinine levels in a mouse model of renal ischemia-reperfusion injury.4
WARNING This product is not for human or veterinary use.
1. Targeting pyruvate kinase M2 and hexokinase II, pachymic acid impairs glucose metabolism and induces mitochondrial apoptosis. Biol. Pharm. Bull. 42(1), 123-129 (2019).
2. Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol. Carcinog. 49(3), 271-282 (2010).
3. Pachymic acid induces apoptosis via activating ROS-
4. Effects and molecular mechanism of pachymic acid on ferroptosis in renal ischemia reperfusion injury. Mol. Med. Rep. 23(1), 1 (2021).